Cargando…
Characterization of SARS-CoV-2 replication complex elongation and proofreading activity
The replication complex (RC) of SARS-CoV-2 was recently shown to be one of the fastest RNA-dependent RNA polymerases of any known coronavirus. With this rapid elongation, the RC is more prone to incorporate mismatches during elongation, resulting in a highly variable genomic sequence. Such mutations...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185715/ https://www.ncbi.nlm.nih.gov/pubmed/35688849 http://dx.doi.org/10.1038/s41598-022-13380-1 |
_version_ | 1784724779361632256 |
---|---|
author | Jones, Alisha N. Mourão, André Czarna, Anna Matsuda, Alex Fino, Roberto Pyrc, Krzysztof Sattler, Michael Popowicz, Grzegorz M. |
author_facet | Jones, Alisha N. Mourão, André Czarna, Anna Matsuda, Alex Fino, Roberto Pyrc, Krzysztof Sattler, Michael Popowicz, Grzegorz M. |
author_sort | Jones, Alisha N. |
collection | PubMed |
description | The replication complex (RC) of SARS-CoV-2 was recently shown to be one of the fastest RNA-dependent RNA polymerases of any known coronavirus. With this rapid elongation, the RC is more prone to incorporate mismatches during elongation, resulting in a highly variable genomic sequence. Such mutations render the design of viral protein targets difficult, as drugs optimized for a given viral protein sequence can quickly become inefficient as the genomic sequence evolves. Here, we use biochemical experiments to characterize features of RNA template recognition and elongation fidelity of the SARS-CoV-2 RdRp, and the role of the exonuclease, nsp14. Our study highlights the 2′OH group of the RNA ribose as a critical component for RdRp template recognition and elongation. We show that RdRp fidelity is reduced in the presence of the 3′ deoxy-terminator nucleotide 3′dATP, which promotes the incorporation of mismatched nucleotides (leading to U:C, U:G, U:U, C:U, and A:C base pairs). We find that the nsp10–nsp14 heterodimer is unable to degrade RNA products lacking free 2′OH or 3′OH ribose groups. Our results suggest the potential use of 3′ deoxy-terminator nucleotides in RNA-derived oligonucleotide inhibitors as antivirals against SARS-CoV-2. |
format | Online Article Text |
id | pubmed-9185715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91857152022-06-10 Characterization of SARS-CoV-2 replication complex elongation and proofreading activity Jones, Alisha N. Mourão, André Czarna, Anna Matsuda, Alex Fino, Roberto Pyrc, Krzysztof Sattler, Michael Popowicz, Grzegorz M. Sci Rep Article The replication complex (RC) of SARS-CoV-2 was recently shown to be one of the fastest RNA-dependent RNA polymerases of any known coronavirus. With this rapid elongation, the RC is more prone to incorporate mismatches during elongation, resulting in a highly variable genomic sequence. Such mutations render the design of viral protein targets difficult, as drugs optimized for a given viral protein sequence can quickly become inefficient as the genomic sequence evolves. Here, we use biochemical experiments to characterize features of RNA template recognition and elongation fidelity of the SARS-CoV-2 RdRp, and the role of the exonuclease, nsp14. Our study highlights the 2′OH group of the RNA ribose as a critical component for RdRp template recognition and elongation. We show that RdRp fidelity is reduced in the presence of the 3′ deoxy-terminator nucleotide 3′dATP, which promotes the incorporation of mismatched nucleotides (leading to U:C, U:G, U:U, C:U, and A:C base pairs). We find that the nsp10–nsp14 heterodimer is unable to degrade RNA products lacking free 2′OH or 3′OH ribose groups. Our results suggest the potential use of 3′ deoxy-terminator nucleotides in RNA-derived oligonucleotide inhibitors as antivirals against SARS-CoV-2. Nature Publishing Group UK 2022-06-10 /pmc/articles/PMC9185715/ /pubmed/35688849 http://dx.doi.org/10.1038/s41598-022-13380-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Jones, Alisha N. Mourão, André Czarna, Anna Matsuda, Alex Fino, Roberto Pyrc, Krzysztof Sattler, Michael Popowicz, Grzegorz M. Characterization of SARS-CoV-2 replication complex elongation and proofreading activity |
title | Characterization of SARS-CoV-2 replication complex elongation and proofreading activity |
title_full | Characterization of SARS-CoV-2 replication complex elongation and proofreading activity |
title_fullStr | Characterization of SARS-CoV-2 replication complex elongation and proofreading activity |
title_full_unstemmed | Characterization of SARS-CoV-2 replication complex elongation and proofreading activity |
title_short | Characterization of SARS-CoV-2 replication complex elongation and proofreading activity |
title_sort | characterization of sars-cov-2 replication complex elongation and proofreading activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185715/ https://www.ncbi.nlm.nih.gov/pubmed/35688849 http://dx.doi.org/10.1038/s41598-022-13380-1 |
work_keys_str_mv | AT jonesalishan characterizationofsarscov2replicationcomplexelongationandproofreadingactivity AT mouraoandre characterizationofsarscov2replicationcomplexelongationandproofreadingactivity AT czarnaanna characterizationofsarscov2replicationcomplexelongationandproofreadingactivity AT matsudaalex characterizationofsarscov2replicationcomplexelongationandproofreadingactivity AT finoroberto characterizationofsarscov2replicationcomplexelongationandproofreadingactivity AT pyrckrzysztof characterizationofsarscov2replicationcomplexelongationandproofreadingactivity AT sattlermichael characterizationofsarscov2replicationcomplexelongationandproofreadingactivity AT popowiczgrzegorzm characterizationofsarscov2replicationcomplexelongationandproofreadingactivity |